Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Interleukin 2 (IL2)

3

X.c Capillary leak syndrome (CLS)

2
Last update : 23/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study.
Diagnostics (Basel, Switzerland) 2022 May 30;12; 2022 May 30
[Radiologic characteristics of the thorax during therapy with interleukin-2].
La Radiologia medica 1992 Oct;84;368-71 1992 Oct
Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer.
Blood 1991 Sep 15;78;1538-44 1991 Sep 15
Cardiorespiratory effects of immunotherapy with interleukin-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989 Jan;7;7-20 1989 Jan
Cardiopulmonary toxicity of adoptive immunotherapy.
The American journal of the medical sciences 1988 Dec;296;406-12 1988 Dec
Clinical effects and toxicity of interleukin-2 in patients with cancer.
Cancer 1986 Dec 15;58;2764-72 1986 Dec 15

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies